This information was published on 2024-07-08T08:19:28 for IP Right Registration Published.
| Field | Value |
| (210) | 2424720 (IR 1773977) |
| (220) |
21 Dec 2023
|
| (300) |
US, 01 Aug 2023, 98112138
|
| (511) (510) |
Class 5
Pharmaceutical products, namely, modified antibodies and modified derivatives of antibodies that promote an immune response, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders. Class 42 Discovery, research, development, engineering, and testing of pharmaceuticals and substances, namely, functional molecules that promote binding to immune cells and disease cells, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders. |
| (540) | MATE |
| (550) | Word |
| (730) |
Biohaven Therapeutics Ltd.
|
| (750) |
Spruson & Ferguson
|
Find out more about publications on the About page.